To comply with FTC regulations, all links on this site could lead to commissions paid to the publisher. Please see Advertising Disclosure in sidebar.
COLUMBIA, MO – Night-shift workers face an increased risk of obesity and diabetes, but the underlying reason for that has been a mystery. Now, University of Missouri School of Medicine researchers have found a potential cause for metabolic changes during night-shift work that creates confusion between cells in the body and the central clock in the brain.
“We hypothesized that the messages cells produce and send each other during night work are different than those sent during the day shift,” said David Gozal, MD, the Marie M. and Harry L. Smith Endowed Chair of Child Health at the MU School of Medicine. “These messages come via microscopic packages called exosomes. Our study found these packages disrupt the synchronicity of the body’s systems during night shifts and cause increased insulin resistance and other health issues.”
Gozal and MU collaborator Abdelnaby Khalyfa, PhD, associate professor, studied 14 participants who were assigned to either a simulated day shift or night shift. After the participants spent three days on the simulated shift, researchers drew their blood every 3 hours, extracted the exosomes from the plasma and delivered them into naïve fat cells. The goal was to examine any potential changes to the fat cells and the key genes that affect metabolism. They found that exosomes taken from the night-shift participants reduced insulin sensitivity of the fat cells. They also discovered that those exosomes contained specialized gene regulators called microRNAs that shifted the internal clock of the fat cells.
“The cells in your body do not adjust as quickly as the central clock in the brain to shifts in sleep patterns,” Gozal said. “So when night-shift workers abruptly shift back and forth to daytime hours on the weekend, the cells in the body continue to send messages to each other through exosomes that lag behind the central clock. It creates a condition called ‘circadian misalignment,’ which is associated with an increased risk for cancer, diabetes, cardiovascular disease and other illnesses.”
Big Tech is censoring our publication severely reducing our traffic and revenue. (How they do it: NewsGuard) You can support our mission of truthful reporting by making a contribution. We refuse to let Silicon Valley crush us into becoming just another regurgitated, propaganda driven, echo-chamber of traditional news media and we need your support. You can also help by signing up for our featured story emails.
Gozal believes using exosomes taken from the blood as a marker of circadian misalignment could play a key role in identifying treatments to prevent the long-term health complications of night-shift work.
“By sampling the blood of workers at different times of the day and examining their exosomes, we might be able to identify whether they are misaligned,” Gozal said. “This could give us a lot of information about which workers are better suited to work night shift. And this discovery raises the possibility of developing personalized less risk-generating shift schedules and also gene-targeted therapeutic approaches to prevent the long-term health complications of night-shift work.”
In addition to Gozal and Khalyfa, MU colleague Leila Kheirandish-Gozal, MD, director of the Child Health Research Institute, contributed to the article along with their collaborators at Washington State University.
The study, “Circulating Exosomal miRNAs Signal Circadian Misalingment to Peripheral Metabolic Tissues,” was recently published in the International Journal of Molecular Sciences. Research reported in this publication was supported by the National Institutes of Health, the Human Sleep and Cognition Laboratory of the Sleep and Performance Research Center and start-up funds from the College of Pharmacy and Pharmaceutical Sciences at Washington State University. Additional funding came from the Leda Sears Foundation Trust. The authors of the study declare that they have no conflicts of interest related to this study. The content is solely the responsibility of the authors and does not necessarily represent the views of the funding agencies.
About University of Missouri Health Care and the University of Missouri School of Medicine
MU Health Care and the MU School of Medicine form an academic health system dedicated to patient care, research and education. Caring for patients from each of Missouri’s 114 counties, both enterprises focus on advancing care for the simplest and most complex conditions, researching breakthroughs for today’s most prevalent health problems and training the next generation of health care providers. With a combined expertise of nearly 7,000 faculty physicians, researchers, nurses and other health care professionals, the academic health system educates over 2,000 students, residents and fellows each year and serves nearly 240,000 patients. For more information, visit muhealth.org and medicine.missouri.edu.